covaxin approval soon? who chief scientist says phase-3 trial data looks good | breaking news
Published 3 years ago • 35K plays • Length 5:40Download video MP4
Download video MP3
Similar videos
-
2:47
covaxin approval: who chief scientist says phase-3 data looks promising| covid-19| oneindia news
-
1:21
bharat biotech’s covaxin's phase 3 trial data looks good: who chief scientist
-
2:53
big boost for covaxin: india's covid vaccine may get who nod | india today
-
5:11
big boost for covaxin: made in india covid vaccine likely to get who nod | sneha mordani's report
-
10:26
covid-19 vaccine: bharat biotech releases covaxin's phase 3 trial data, claims 77.8% efficacy
-
4:01
man with vaccine side-effect has message for unvaccinated
-
6:24
covid-19: researcher blows the whistle on data integrity issues in pfizer’s vaccine trial
-
4:48
novak djokovic breaks silence over covid vaccine refusal - bbc news
-
4:35
good news! who nod for bharat biotech's covaxin covid-19 vaccine expected by september-end
-
1:41
covaxin to get who nod soon? chief scientist says covid-19 vaccine trial data 'looks good'
-
6:25
coronavirus vaccine news: covaxin awaits who nod | india today's report
-
1:13
'looks good': covaxin likely to get who nod very soon
-
22:58
covaxin data looks good, who nod expected by september end, says dr. v.k. paul | exclusive
-
24:04
who chief scientist soumya swaminathan: covaxin approval in process | viewpoint | cnn news18
-
1:33
covaxin phase 3 trial data approved by subject expert committee, shows 77.8 % efficacy
-
44:17
how effective is india's covaxin again covid and delta | here's what the numbers reveal
-
2:35
bharat biotech to meet who to get eul approval
-
8:40
decoding covaxin's final phase 3 trial data with dr shahid jameel | the quint
-
8:34
covaxin approved for trial on children above 12 years, covishield above age 18| covid vaccine news
-
0:44
good news for those who have taken covaxin; who set to give nod to bharat biotech's vaccine
-
2:20
crucial who meeting on bharat biotech's covaxin approval concludes | breaking news
-
14:19
explained: the main concerns with bharat biotech's covaxin approval | the quint